AML Panel Deletion/Duplication Detection
Comprehensive Genetic Analysis for Acute Myeloid Leukemia
The AML Panel Deletion/Duplication Detection represents a cutting-edge approach to genetic testing in hematologic malignancies. This specialized diagnostic tool provides crucial insights into the genetic landscape of Acute Myeloid Leukemia, enabling healthcare providers to make informed decisions about treatment strategies and patient management.
What This Test Measures and Detects
This advanced genetic panel utilizes MLPA (Multiplex Ligation-dependent Probe Amplification) technology to identify specific chromosomal abnormalities associated with AML. The test focuses on detecting:
- Gene deletions affecting critical regions involved in leukemia development
- Chromosomal duplications that may indicate disease progression
- Specific genetic markers associated with treatment response
- Abnormalities in genes regulating cell growth and differentiation
- Genetic variations that influence prognosis and survival outcomes
Who Should Consider This Test
This comprehensive genetic analysis is recommended for individuals experiencing:
- Unexplained fatigue, weakness, or persistent infections
- Unusual bleeding or bruising tendencies
- Frequent fevers without apparent cause
- Bone pain or joint discomfort
- Unexplained weight loss and loss of appetite
- Paleness or shortness of breath
- Enlarged lymph nodes, liver, or spleen
- Patients with confirmed AML requiring genetic profiling
- Individuals with family history of hematologic malignancies
Key Benefits of AML Genetic Testing
Undergoing the AML Panel Deletion/Duplication Detection offers numerous advantages:
- Precise Diagnosis: Provides accurate identification of specific genetic abnormalities
- Personalized Treatment: Enables targeted therapy selection based on genetic profile
- Prognostic Information: Helps predict disease course and treatment response
- Risk Stratification: Assists in determining appropriate treatment intensity
- Monitoring Tool: Can be used to track disease progression and treatment effectiveness
- Family Planning: Provides information about potential hereditary factors
Understanding Your Test Results
Your AML Panel results will provide detailed information about detected genetic abnormalities. Positive findings indicate specific deletions or duplications that may influence your treatment plan. Negative results suggest the absence of commonly tested genetic abnormalities, though additional testing may be recommended based on clinical presentation. Our genetic counselors are available to help interpret your results and discuss implications for your care.
Test Details and Pricing
| Test Parameter | Details |
|---|---|
| Test Name | AML Panel Deletion/Duplication Detection |
| Regular Price | $350 USD |
| Discount Price | $262 USD |
| Turnaround Time | 7-10 days |
| Sample Type | Bone marrow / Peripheral blood (Transport immediately) |
| Test Components | EDTA Vacutainer (2ml) |
| Testing Method | MLPA (Multiplex Ligation-dependent Probe Amplification) |
Pre-Test Instructions
The AML Panel Deletion/Duplication Detection requires a Doctor’s prescription. Please note that prescription requirements do not apply for surgery and pregnancy cases or individuals planning to travel abroad. Ensure proper sample collection and immediate transport to maintain sample integrity.
Nationwide Accessibility
We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our extensive network ensures convenient access to this advanced genetic testing service.
Take the Next Step Toward Better Health
Don’t wait to get the critical genetic information you need for optimal leukemia management. Our experienced team is ready to assist you with scheduling, sample collection, and result interpretation.
Call or WhatsApp us today at +1(267) 388-9828 to book your AML Panel Deletion/Duplication Detection test and take control of your health journey.
